SG152048A1 - A process for the extraction, purification and enzymatic modification of soy 7s globulin alphaæ subunit foruse as hypocholesterolemizing agent - Google Patents

A process for the extraction, purification and enzymatic modification of soy 7s globulin alphaæ subunit foruse as hypocholesterolemizing agent

Info

Publication number
SG152048A1
SG152048A1 SG200506973-7A SG2005069737A SG152048A1 SG 152048 A1 SG152048 A1 SG 152048A1 SG 2005069737 A SG2005069737 A SG 2005069737A SG 152048 A1 SG152048 A1 SG 152048A1
Authority
SG
Singapore
Prior art keywords
subunit
soy
purification
extraction
hypocholesterolemizing
Prior art date
Application number
SG200506973-7A
Other languages
English (en)
Inventor
Marcello Duranti
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of SG152048A1 publication Critical patent/SG152048A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/14—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from leguminous or other vegetable seeds; from press-cake or oil-bearing seeds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/16—Vegetable proteins from soybean
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06—Ethanol, i.e. non-beverage
    • C—CHEMISTRY; METALLURGY
    • C13—SUGAR INDUSTRY
    • C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K1/00—Glucose; Glucose-containing syrups
    • C13K1/06—Glucose; Glucose-containing syrups obtained by saccharification of starch or raw materials containing starch
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG200506973-7A 2002-01-29 2003-01-27 A process for the extraction, purification and enzymatic modification of soy 7s globulin alphaæ subunit foruse as hypocholesterolemizing agent SG152048A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000147A ITMI20020147A1 (it) 2002-01-29 2002-01-29 Estrazione purificazione e modificazione di polipeptidi da seme di soia

Publications (1)

Publication Number Publication Date
SG152048A1 true SG152048A1 (en) 2009-05-29

Family

ID=11449014

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200506973-7A SG152048A1 (en) 2002-01-29 2003-01-27 A process for the extraction, purification and enzymatic modification of soy 7s globulin alphaæ subunit foruse as hypocholesterolemizing agent

Country Status (20)

Country Link
US (3) US7465467B2 (cg-RX-API-DMAC7.html)
EP (1) EP1469741B1 (cg-RX-API-DMAC7.html)
JP (1) JP4522706B2 (cg-RX-API-DMAC7.html)
KR (1) KR100991641B1 (cg-RX-API-DMAC7.html)
CN (1) CN100558243C (cg-RX-API-DMAC7.html)
AT (1) ATE341943T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003208346B8 (cg-RX-API-DMAC7.html)
CA (1) CA2474106C (cg-RX-API-DMAC7.html)
CY (1) CY1107514T1 (cg-RX-API-DMAC7.html)
DE (1) DE60308994T2 (cg-RX-API-DMAC7.html)
DK (1) DK1469741T3 (cg-RX-API-DMAC7.html)
ES (1) ES2274208T3 (cg-RX-API-DMAC7.html)
IL (1) IL163225A (cg-RX-API-DMAC7.html)
IT (1) ITMI20020147A1 (cg-RX-API-DMAC7.html)
NO (1) NO327156B1 (cg-RX-API-DMAC7.html)
PL (1) PL209342B1 (cg-RX-API-DMAC7.html)
PT (1) PT1469741E (cg-RX-API-DMAC7.html)
RU (1) RU2300898C2 (cg-RX-API-DMAC7.html)
SG (1) SG152048A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003063608A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
AU2003275628B2 (en) * 2002-11-12 2008-04-03 Fuji Oil Company, Limited Fractionated soybean protein and process for producing the same
WO2005055735A1 (ja) * 2003-12-11 2005-06-23 Fuji Oil Company, Limited 改良大豆7sたん白及びその製造法
JP5382840B2 (ja) * 2005-08-23 2014-01-08 特定非営利活動法人プライメイト・アゴラ サルモデルで薬効が確認された骨粗鬆症の予防又は治療剤
BRPI0918680A2 (pt) * 2008-12-31 2015-08-25 Solae Llc "composição de proteína de soja hidrolisada, fração da proteína, produto alimentício, processo para a fabricação de uma fração de proteína, processo para a produção de um produto de proteína e produto alimentício"
EP2264054A1 (en) * 2009-06-17 2010-12-22 Indena S.p.A. Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin alfa ' subunit involved in Hep G2 cell cholesterol homeostasis
PL2264055T3 (pl) * 2009-06-17 2014-09-30 Indena Spa Klonowanie, ekspresja w drożdżach i aktywność biologiczna regionu wydłużenia podjednostki alfa globuliny sojowej 7S zaangażowanej w homeostazę cholesterolu w komórkach HepG2
CN101904406B (zh) * 2010-07-02 2012-07-25 山西大学 一种葵花籽多肽的制备方法和用途
CN104163767B (zh) * 2014-07-25 2017-01-18 湖北泓肽生物科技有限公司 一种氨基酸和多肽水溶性物质的纯化方法
CN114874301A (zh) * 2022-05-10 2022-08-09 吉林农业大学 不同亚基组成β-伴大豆球蛋白的制备方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409248A (en) 1981-08-10 1983-10-11 A. E. Staley Manufacturing Company Heat-gelling and foam-stabilizing enzymatically modified vegetable isolates
JPH06197788A (ja) * 1993-01-06 1994-07-19 Fuji Oil Co Ltd 蛋白質の製造法
ES2139420T3 (es) 1996-03-28 2000-02-01 Fuji Oil Co Ltd Un procedimiento para producir un hidrolizado de proteina de soja.
JP3928811B2 (ja) * 1996-06-14 2007-06-13 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 特定のクラスのダイズ種子タンパク質遺伝子の抑制
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
US6365802B2 (en) * 1998-08-14 2002-04-02 Calgene Llc Methods for increasing stearate content in soybean oil
FR2784029B1 (fr) * 1998-10-05 2001-01-05 Pharmascience Lab Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie
PT1190068E (pt) * 1999-04-15 2006-06-30 Calgene Llc Sequencias de acidos nucleicos para proteinas envolvidas na sintese de tocoferol
CA2274414A1 (en) * 1999-06-11 2000-12-11 Universite Laval Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
AUPQ877300A0 (en) 2000-07-13 2000-08-03 Johnson & Johnson Pacific Pty Limited Topical treatment of skin
BRPI0309421B8 (pt) * 2002-04-18 2021-05-25 Monsanto Technology Llc método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
CA2477922C (en) * 2003-08-20 2010-10-26 Seikagaku Corporation Stabilizing agent for enzymes
MX2007008496A (es) * 2005-01-14 2007-09-14 Solae Llc Proteina de soya para formula infantil.

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BETA CONGLYCININ FROM SOYBEAN PROTEINS. ISOLATION AND IMMUNOLOGICAL AN *
PILOT-PLANT FRACTIONATION OF SOYBEAN GLYCININ AND BETA-CONGLYCININ *
SIMPLIFIED PROCESS FOR SOYBEAN GLYCININ AND BETA-CONGLYCININ FACTIONATION *

Also Published As

Publication number Publication date
ATE341943T1 (de) 2006-11-15
CA2474106A1 (en) 2003-08-07
KR20040077786A (ko) 2004-09-06
ITMI20020147A0 (it) 2002-01-29
RU2300898C2 (ru) 2007-06-20
US7901718B2 (en) 2011-03-08
US8257758B2 (en) 2012-09-04
ES2274208T3 (es) 2007-05-16
PL209342B1 (pl) 2011-08-31
CN100558243C (zh) 2009-11-11
IL163225A (en) 2007-06-17
DK1469741T3 (da) 2007-02-19
KR100991641B1 (ko) 2010-11-04
US20080261885A1 (en) 2008-10-23
CY1107514T1 (el) 2013-03-13
CN1622760A (zh) 2005-06-01
ITMI20020147A1 (it) 2003-07-29
NO20043186L (no) 2004-07-26
PL370294A1 (en) 2005-05-16
AU2003208346A2 (en) 2003-09-02
US20050164337A1 (en) 2005-07-28
AU2003208346B2 (en) 2008-03-06
JP4522706B2 (ja) 2010-08-11
EP1469741B1 (en) 2006-10-11
DE60308994T2 (de) 2007-06-14
US7465467B2 (en) 2008-12-16
AU2003208346B8 (en) 2008-07-10
RU2004123201A (ru) 2005-10-27
EP1469741A1 (en) 2004-10-27
PT1469741E (pt) 2007-01-31
NO327156B1 (no) 2009-05-04
CA2474106C (en) 2011-11-22
JP2005516043A (ja) 2005-06-02
DE60308994D1 (de) 2006-11-23
WO2003063608A1 (en) 2003-08-07
HK1073590A1 (zh) 2005-10-14
US20110118182A1 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
White Jr et al. Some relationships of structure to function in ribonuclease
AU7569501A (en) Codon-optimized papilloma virus sequences
MX9701869A (es) Inhibidor de la proteasa leucocitaria secretoria como inhibidor de la triptasa.
EP1505990A4 (en) METHOD FOR THE TREATMENT OF HEPATITIS
MXPA03000612A (es) Metodos y procesos mejorados para desinfeccion con yodo.
PL370294A1 (en) A process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
EP1997510A8 (de) Nicht-neurotoxische Plasminogen Aktivierende Faktoren zur Behandlung von Schlaganfall
WO2004043373A3 (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
JP2005516043A5 (cg-RX-API-DMAC7.html)
GB0422989D0 (en) Methods and agents for the treatment of cancer
PL376973A1 (pl) Sposób oczyszczania monoazotanu 1,4-butanodiolu
DE59813491D1 (de) Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
MD2377F1 (en) Method of treatment of puerperal endometritis
DK1392874T3 (da) Hidtil ukendt porös svovljernsvampforbindelse, fremgangsmåde til fremstilling deraf og fremgangsmåde til afsvovling af naturgas med denne
Zhu et al. Recovery of Palladium from Acidic Solutions with Solvent Extraction.
WO2002070551A3 (en) Neuritogenic compound and uses thereof
WO2001075060A3 (en) A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide
WO2001075018A3 (fr) Nouveau polypeptide, facteur humain de regulation de la transcription 31, et polynucleotide codant pour ce polypeptide
WO2001075005A3 (fr) Nouveau polypeptide, sous-unite c de l'atpase pompe a protons vacuolaire (v-atpase) 12, et polynucleotide codant pour ce polypeptide
WO2001079432A3 (fr) Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 58, et polynucleotide codant pour ce polypeptide
WO2001075058A3 (en) A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001075004A3 (fr) Nouveau polypeptide, enzyme de conjugaison de l'ubiquitine 9, et polynucléotide codant pour ce polypeptide
WO2005056574A3 (en) Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001094534A3 (fr) Nouveau polypeptide, facteur humain de transcription 9.57, et polynucleotide codant ce polypeptide